Gonadal function following chemotherapy for childhood Hodgkin's disease.
Affiliation
Department of Paediatric Oncology, The Christie Hospital, NHS Trust, Manchester, United Kingdom.Issue Date
1996-08
Metadata
Show full item recordAbstract
Gonadal function was assessed in 101 postpubertal subjects after chemotherapy for childhood Hodgkin's disease. All had received ChlVPP (chlorambucil, vinblastine, procarbazine, and prednisolone) chemotherapy alone, with no radiotherapy below the diaphragm. Gonadotropin levels were available in 46 (79.3%) male and 32 (74.4%) female subjects. The mean age at diagnosis in the male cohort was 12.2 years (range 8.2-15.3) and in the females 13.0 years (9.0-15.2). The males and the females were studied at a median of 6 years (range 2.5-11.1) and 4.3 years (range 1.9-11.5) from diagnosis, respectively. Forty-one (89.1%) male subjects had elevated follicle-stimulating hormone (FSH) levels, confirming severe germinal epithelial damage. Germinal epithelial damage was seen in subjects up to 10 years out of therapy. Subtle Leydig cell dysfunction was identified in 24.4% with raised luteinzing hormone (LH) levels. All subjects, however, progressed spontaneously through puberty. Seventeen (53%) women had raised gonadotropin levels, with variable estradiol levels. Of these, 10 subjects presented with symptomatic ovarian failure and 6 received hormone replacement therapy (HRT). Nine women had 11 successful pregnancies, two of whom had previously had symptoms of ovarian failure with one requiring HRT. A much higher prevalence of ovarian failure has been observed, than has previously been considered in the prepubertal and pubertal female following combination chemotherapy. These conclusions have important implications for future counseling, management, and research in this population.Citation
Gonadal function following chemotherapy for childhood Hodgkin's disease. 1996, 27 (2):74-8 Med. Pediatr. Oncol.Journal
Medical and Pediatric OncologyDOI
10.1002/(SICI)1096-911X(199608)27:2<74::AID-MPO2>3.0.CO;2-QPubMed ID
8649323Type
ArticleLanguage
enISSN
0098-1532ae974a485f413a2113503eed53cd6c53
10.1002/(SICI)1096-911X(199608)27:2<74::AID-MPO2>3.0.CO;2-Q
Scopus Count
Collections
Related articles
- Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
- Authors: Clark ST, Radford JA, Crowther D, Swindell R, Shalet SM
- Issue date: 1995 Jan
- Testicular function following the treatment of Hodgkin's disease in childhood.
- Authors: Shafford EA, Kingston JE, Malpas JS, Plowman PN, Pritchard J, Savage MO, Eden OB
- Issue date: 1993 Dec
- Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
- Authors: Dhabhar BN, Malhotra H, Joseph R, Garde S, Bhasin S, Sheth A, Advani SH
- Issue date: 1993 Aug
- Gonadal function and fertility in male survivors treated for Hodgkin's disease in Iran.
- Authors: Rafsanjani KA, Faranoush M, Hedayatiasl AA, Vossough P
- Issue date: 2007 Nov
- Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
- Authors: van Beek RD, Smit M, van den Heuvel-Eibrink MM, de Jong FH, Hakvoort-Cammel FG, van den Bos C, van den Berg H, Weber RF, Pieters R, de Muinck Keizer-Schrama SM
- Issue date: 2007 Dec